TMBIM4 and depressive disorder: When used to treat depression or anxiety, SSRIs may take several weeks for full benefit, but fluvoxamine's S1R agonist action has immediate effects on the activity of a transcription factor that regulates the production of cytokines in response to inflammatory triggers [3].